瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - dimetylfumarat - enterokapsel, hård - 120 mg - propylenglykol hjälpämne; dimetylfumarat 120 mg aktiv substans

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

zentiva k.s. - dimetylfumarat - enterokapsel, hård - 240 mg - dimetylfumarat 240 mg aktiv substans; propylenglykol hjälpämne

欧盟 - 瑞典文 - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 och 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

欧盟 - 瑞典文 - EMA (European Medicines Agency)

biogen netherlands b.v.  - fampridine - multipel skleros - andra nervsystemet droger - fampyra är indicerat för förbättring av vandring hos vuxna patienter med multipel skleros med gångavstånd (utökad disability status scale 4-7).

欧盟 - 瑞典文 - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - ozanimod hydroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunsuppressiva - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

欧盟 - 瑞典文 - EMA (European Medicines Agency)

accord healthcare s.l.u. - fampridine - multipel skleros - andra nervsystemet droger - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

欧盟 - 瑞典文 - EMA (European Medicines Agency)

mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

欧盟 - 瑞典文 - EMA (European Medicines Agency)

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

瑞典 - 瑞典文 - Läkemedelsverket (Medical Products Agency)

medical valley invest ab - fampridin - depottablett - 10 mg - fampridin 10 mg aktiv substans

欧盟 - 瑞典文 - EMA (European Medicines Agency)

teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).